This inventor holds 3 USPTO granted patents. Top assignee: The University of Tokyo. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Anqi Tao: Innovator in Drug Delivery Systems
Introduction
Anqi Tao is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of drug delivery systems, holding a total of 3 patents. Her innovative work focuses on enhancing the efficacy of drug delivery while minimizing potential side effects.
Latest Patents
One of her latest patents is titled "Delivery of cyclic compound by using carrier." This invention describes a drug delivery system that effectively delivers a cyclic compound to a target cell or tissue while suppressing the pharmacological activity of the compound. The system includes a complex that consists of the cyclic compound and a delivery carrier, which has a shaft portion designed to carry the cyclic compound. This shaft portion is complexed by inclusion in the cyclic compound, forming a host-guest complex.
Another notable patent is the "Protein-enclosing polymeric micelle." This invention provides a polymeric complex that comprises a protein and a block copolymer, which is represented by a specific formula. This innovative approach aims to improve the stability and delivery of therapeutic proteins.
Career Highlights
Anqi Tao is affiliated with The University of Tokyo, where she conducts her research and development in drug delivery systems. Her work has garnered attention for its potential applications in medical treatments and therapies.
Collaborations
Throughout her career, Anqi has collaborated with notable colleagues, including Horacio Cabral and Takuya Miyazaki. These collaborations have further enriched her research and contributed to the advancement of her inventions.
Conclusion
Anqi Tao is a trailblazer in the field of drug delivery systems, with a focus on innovative solutions that enhance therapeutic efficacy. Her contributions are paving the way for future advancements in medical technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
